Body mass index, airflow obstruction, dyspnea, and exercise index is not modified after 6 months therapy with roflumilast in a cohort of patients with chronic obstructive pulmonary disease

Lung India. 2016 Sep-Oct;33(5):579-80. doi: 10.4103/0970-2113.189000.
No abstract available